Search

Issue
Title
Authors
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E.V., Dudnikova A.V.
Fixed-dose combinations of hypoglycemic drugs: potential of alogliptin/pioglitazone in type 2 diabetes mellitus: a review
Butranova O.I., Zyryanov S.K., Melnikova A.R., Matsepuro A.E.
Gut microbiota: Historical essay and role in nephrology
Nezhdanov K.S., Milovanova L.Y., Milovanova S.Y., Taranova M.V., Volkov A.V., Androsova T.V.
Factors associated with the outcomes of ANCA-associated glomerulonephritis: a retrospective cohort study
Bulanov N.M., Tao E.A., Stoliarevich E.S., Bulanova M.L., Litvinova M.A., Skvortsov A.V., Kokhanchuk V.A., Novikov P.I., Kuchieva A.M., Kadorkina T.S., Vasilyeva M.P., Moiseev S.V.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V.V., Shamkhalova M.S., Duganova A.V.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V.V., Pulin A.A., Mukhin N.A.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E.L., Vaizova O.E., Meleshko M.V., Samoilova I.G., Podchinenova D.V., Borozinets A.A., Matveeva M.V., Kudlay D.A.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G.P., Tarlovskaia E.I., Koziolova N.A., Boldina M.V., Batiushin M.M., Ametov A.S., Arutiunov A.G., Belevskii A.S., Galstian G.R., Grigor’eva N.I., Dzhunusbekova G.A., Esaian A.M., Mal’chikova S.V., Mit’kovskaia N.P., Mkrtumian A.M., Orlova I.A., Petrova M.M., Rebrov A.P., Ruzanov D.I., Salukhov V.V., Sisakian A.S., Skibitskii V.V., Sugraliev A.B., Fomin I.V., Khalimov I.S., Chesnikova A.I., Shaposhnik I.I., Shestakova M.V.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M.V., Kotovskaya Y.V., Ivashkin V.T., Tkacheva O.N., Troshina E.A., Shestakova M.V., Breder V.V., Geyvandova N.I., Doshchitsin V.L., Dudinskaya E.N., Ershova E.V., Kodzoeva K.B., Komshilova K.A., Korochanskaya N.V., Mayorov A.Y., Mishina E.E., Nadinskaya M.Y., Nikitin I.G., Pogosova N.V., Tarzimanova A.I., Shamkhalova M.S.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O.O., Komarov A.L., Krivosheeva E.N., Dobrovolsky A.B., Titaeva E.V., Amelyushkina V.A., Gomyranova N.V., Panchenko E.P.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N.V., Gulyaev S.V., Androsova T.V., Popova E.N., Gurova D.V., Novikov P.I., Milovanova L.Y., Moiseev S.V.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E.V., Dmitriev V.A., Titov V.N.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S.V., Karovaikina E.A., Bulanov N.M., Moiseev A.S., Fomin V.V.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O.M., Martynov A.I., Arutyunov G.P., Bakulin I.G., Livzan M.A., Maev I.V., Egorov I.V.
The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
Karetnikova V.N., Kalaeva V.V., Evseeva M.V., Osokina A.V., Kashtalap V.V., Gruzdeva O.V., Shafranskaya K.S., Zykov M.V., Barbarash O.L.
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
Demyanova K.A., Kozlovskaya N.L., Korotchaeva Y.V., Apresyan S.V., Rylceva L.P., Usatenko G.V., Lugovoj A.O., Vorobyeva M.A., Bondarenko T.V., Bespalova A.V., Volkova O.A.
Epidemiology of chronic renal disease in the Northwest of Russia: setting-up the register
Dobronravov V.A., Smirnov A.V., Dragunov S.V., Zverkov R.V., Evdokimova T.V., Butrimova S.S., Grigorschuk V.I.
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G.P., Lopatin Y.M., Ametov A.S., Ageev F.T., Antsiferov M.B., Villevalde S.V., Vinogradova N.G., Galstyan G.R., Galyavich A.S., Gilyarevskiy S.R., Glezer M.G., Zhirov I.V., Ilyin M.V., Lebedeva A.I., Nedogoda S.M., Salukhov V.V., Tarlovskaya E.I., Tereshchenko S.N., Fomin I.V., Khalimov I.S., Khasanov N.R., Cherkashin D.V., Yakushin S.S.
Current challenges for therapy of comorbid patients: a new look at celecoxib. A review
Zyryanov S.K., Baybulatova E.A.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F.U., Remizov O.V., Goloeva V.G., Ikoeva Z.R.
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease
Mikhailova N.A.
Polyvascular disease in patients with myocardial infarction and chronic kidney disease
Karetnikova V.N., Kalaeva V.V., Evseeva M.V., Gruzdeva O.V., Zykov M.V., Kashtalap V.V., Barbarash O.L.
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery
Gussaova S.S., Bobkova I.N., Yashkov Y.I., Bordan N.S., Stavrovskaya E.V., Bekuzarov D.K., Evdoshenko V.V., Fedenko V.V., Malykhina A.I., Struve A.V.
Glycemic control in patients with diabetes mellitus on hemodialysis
Lobanova K.G., Severina A.S., Martinov S.A., Shamkhalova M.S., Shestakova M.V.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N.A., Milovanov Y.S., Kozlovskaya L.V., Dobrosmyslov I.A., Milovanova L.Y.
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
Milovanova L.Y., Milovanov Y.S., Kudryavtseva D.V., Markina M.M., Milovanova S.Y., Kozlovskaya L.V., Lebedeva M.V., Beketov V.D., Moiseev S.V., Mukhin N.A., Fomin V.V., Svistunov A.A.
Chronic kidney disease and vascular dementia
Mukhin N.A., Fomin V.V., Damulin I.V., Rogova I.V.
Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity
Galliamov M.G., Saginova E.A., Severova M.M., Samokhodskaia L.M., Krasnova T.N., Sholomova V.I., Sorokin I.D., Mukhin N.A.
Hyperuricemia as a component of cardiorenal syndrome
Mukhin N.A., Fomin V.V., Lebedeva M.V., Mukhin N.A., Fomin V.V., Lebedeva M.V.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O.N., Abolyan L.V., Kuteinikov V.I., Vinogradov V.E., Fomin V.V.
Normoalbuminuric chronic kidney disease in diabetes
Klimontov V.V., Korbut A.I.
Risk factors for cardiovascular system damage in chronic kidney disease
Kutyrina I.M., Rudenko T.E., Savel'eva S.A., Shvetsov M.I., Vasil'eva M.P.
Specific features of cognitive impairments in patients with predialysis chronic kidney disease
Rogova I.V., Fomin V.V., Damulin I.V., Shashkova E.V.
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.Y.
The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys
Milovanov Y.S., Kozlovskaya L.V., Milovanova L.Y., Milovanov Y.S., Kozlovskaya L.V., Milovanova L.Y.
Calcium antagonists: on the way to expanding the indications
Fomin V.V.
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study
Milovanova L.Y., Taranova M.V., Volkov A.V., Milovanova S.Y., Beketov V.D.
Anticoagulant therapy in patients with atrial fibrillation and reduced kidney function of diabetic and non-diabetic etiologies
Sokolova A.A., Daabul I.S., Tsarev I.L., Napalkov D.A., Fomin V.V.
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression
Shvetsov M.Y., Zheng A., Kozlovskaya L.V., Serova A.G., Travkina E.V., Mukhin N.A.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A.A., Kustova T.I., Fomin V.V., Mukhin N.A.
LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE
Milovanov Y.S., Milovanova L.Y.
Obesity and chronic kidney disease
Bondar' I.A., Klimontov V.V., Simakova A.I., Bondar I.A., Klimontov V.V., Simakova A.I.
Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic disease of the kidneys untreated with replacement renal therapy
Smirnov A.V., Volkov M.M., Galkina O.V., Zhloba A.A., Emanuel' V.L., Smirnov A.V., Volkov M.M., Galkina O.V., Zhloba A.A., Emanel V.L.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N.M., Moiseev S.V.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F.U., Remizov O.V., Botcieva V.K., Goloeva V.G., Malakhova N.G., Ikoeva Z.R.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O.N., Orlova A.A., Rogozhkina E.A., Drapkina O.M.
Diabetes epidemiology in Russia: what has changed over the decade?
Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Dedov I.I.
The role of immune factors in the progression of chronic kidney diseases in HIV infection
Yushchuk N.D., Gadzhikulieva M.M., Balmasova I.P., Volgina G.V., Gultyaev M.M.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F.U., Sopoev M.Y., Gatagonova T.M., Bestaeva T.L., Khamitsaeva O.V.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F.U., Gatagonova T.M., Bestaeva T.L., Sopoev M.I., Bazaeva B.G., Khamitsaeva O.V.
Renal anemia and cardiac remodeling in patient with chronic glomerulonephritis
Murkamilov I.T., Lunegova O.S., Kaliev R.R.
Radionuclide evaluation of renal function in essential hypertensive patients with chronic kidney disease
Musina N.S., Semenova R.I.
Treatment of diabetes mellitus in dialysis patients
Bondar' I.A., Klimontov V.V., Bondar I.A., Klimontov V.V.
The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients
Saginova E.A., Gallyamov M.G., Severova M.M., Surkova O.A., Fomin V.V., Ermakov N.V., Rodina A.V., Mukhin N.A., Saginova E.A., Gallyamov M.G., Severova M.M., Surkova O.A., Fomin V.V., Ermakov N.V., Rodina A.V., Mukhin N.A.
Autonomic imbalance in patients with metabolic syndrome: role in the development of hyperfiltration, an early marker of renal lesion
Gornostayeva E.Y., Novikova M.S., Beloborodova A.V., Akarachkova E.S., Shilov E.M., Shvarkov S.B.
Effect of vitamin D receptor activators on serum Klotho levels in 3b–4 stages chronic кidney disease patients: a prospective randomized study
Milovanova L.Y., Beketov V.D., Milovanova S.Y., Taranova M.V., Kozlov V.V., Pasechnik A.I., Reshetnikov V.A., Androsova T.V., Kalashnikov M.V.
Adenoma of the parathyroid gland in a young woman with chronic kidney disease: primary or tertiary hyperparathyroidism?
Vetchinnikova O.N., Prokopenko E.I., Voronkova I.A.
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants
Chebotareva N.V., Guliaev S.V., Androsova T.V., Milivanova L.U.
Phosphate binders in chronic kidney disease: The positions of sevelamer
Fomin V.V., Shilov E.M., Svistunov A.A., Milovanov I.S.
The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure
Kutyrina I.M., Rudenko T.E., Shvetsov M.I., Kushnir V.V.
Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis
Markina M.V., Milovanova L.Y., Lysenko L.V., Milovanova S.Y., Volkov A.V., Beketov V.D., Lebedeva M.V., Nezhdanov K.S., Moiseev S.V.
Cardiorenal syndromes: historical aspects and current challenges
Nezhdanov K.S., Milovanova L.Y., Strizhakov L.A., Krasnova T.N.
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M.S., Sukhareva O.Y., Shestakova M.V.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M.L., Frolova N.F., Kim I.G., Ushakova A.I., Usatiuk S.S., Iskhakov R.T., Diakova E.N., Chervinko V.I., Volodina E.V., Tomilina N.A., Kryukov E.V.
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review)
Strizhakov L.A., Fomin V.V., Garipova R.V., Babanov S.A., Arkhipov E.V., Lebedeva M.V.
Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Z.A., Bayzhigitova A.A.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M.S., Glazunova A.M., Mikhaleva O.V., Zuraeva Z.T., Martynov S.A., Klefortova I.I., Manchenko O.V., Ulyanova I.N., Ilyin A.V., Shamkhalova M.S., Shestakova M.V.
Prognostic value of renal resistance index in estimating the progression of chronic kidney disease
Gazhonova V.E., Zykova A.S., Chistyakov A.A., Roshchupkina S.V., Romanova M.D., Krasnova T.N.
Hyperfiltration is an early sign of evolving chronic renal disease in males with metabolic syndrome
Novikova M.S., Shilov E.M., Borisov V.V., Novikova M.S., Shilov E.M., Borisov V.V.
End products of glycation (AGEs) and inflammation in the clinic of cardiovascular complications and vascular calcification at different stages of chronic kidney disease (G1–G5D)
Fatima D.U., Remizov O.V., Ikoeva Z.R., Tedeeva I.V., Gusalov A.A., Goloeva V.G.
Frailty and chronic kidney disease – the real problem of modern nephrology: A review
Rudenko T.E., Bobkova I.N., Kamyshova E.S., Stavrovskaya E.V.
The relationship of hypertriglyceridemia and left ventricular remodeling types in patients with chronic kidney disease
Murkamilov I.T., Sabirov I.S., Fomin V.V., Aitbaev K.A., Murkamilova Z.A.
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection
Milovanov Y.S., Mukhin N.A., Kozlovskaya L.V., Milovanova S.Y., Markina M.M.
ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE
Smirnov A.V., Petrischev N.N., Mnuskina M.M., Panina I.Y., Pumyantsev A.S., Vasina E.Y., Achkasova V.V., Menshutina M.A.
Nephroprotective role of early correction of impaired nutritional status in patients with chronic disease of the kidneys at a predialysis stage
Milovanov I.S., Kozlovskaia L.V., Milovanova L.I.
Cardiovascular-kidney-metabolic syndrome: the interdisciplinary approach. A review
Trushina O.I.
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Bobkova I.N.
Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease
Taranova M.V., Milovanova L.Y., Kozlovskaya(Lysenko) L.V., Milovanova S.Y., Androsova T.V., Zubacheva D.O., Lebedeva M.V., Dobrosmyslov I.A., Kozlov V.V., Kuchieva A.M., Li O.A., Reshetnikov V.A.
Nutritional support for patients with chronic kidney disease at pre-dialysis stages
Kuzmina A.V.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I.I., Severina A.S., Shamkhalova M.S., Shestakova M.V.
Nephrological aspects of surgical weight correction in morbid obesity
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V., Struve A.V.
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
Mukhin N.A., Glybochko P.V., Svistunov A.A., Fomin V.V., Kiyakbaev G.G.
Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
Vasilyeva M.P., Rudenko T.E., Kutyrina I.M., Solomakhina N.I.
Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia
Kaliuzhin V.V., Sibireva O.F., Urazova O.I., Tkalich L.M., Zibnitskaia L.I., Kaliuzhina E.V., Sazonov É.A., Grankina V.I.
The level of endothelin-1 and reactivity of skin microvessels in patients with early stages of chronic kidney disease
Smirnov A.V., Petrishchev N.N., Panina I.Y., Mnuskina M.M., Achkasova V.V., Rumyantsev A.S., Menshutina M.A., Smirnov A.V., Petrischev N.N., Panina I.Y., Mnuskina M.M., Achkasova V.V., Rumyantsev A.S., Menshutina M.A.
1 - 85 of 85 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».